Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | MAP3K12 | Q12852 | 12/20 | 0.38 |
| ▸ | MET | P08581 | 1/20 | 0.38 |
| ▸ | AKT1 | P31749 | 2/20 | 0.37 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.36 |
| ▸ | CHRNB4 | P30926 | 4/20 | 0.36 |
| ▸ | CHRNA3 | P32297 | 4/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21557697 | 0.93 | MAPK1 (0.47) | MAPK1MAP3K12METAKT1CHRNB2 | |
| SCHEMBL21558002 | 0.86 | MAPT (0.41) | MAPK1MAP3K12METCHRNB2CHRNB4 | |
| SCHEMBL21557995 | 0.86 | MAPT (0.41) | MAPK1MAP3K12METCHRNB2CHRNB4 | |
| SCHEMBL20504001 | 0.84 | MAPK1 (0.43) | MAPK1CHRNB4CHRNA3 | |
| SCHEMBL21557637 | 0.83 | MAP3K12 (0.48) | MAPK1MAP3K12METCHRNB2CHRNB4 | |
| SCHEMBL21557944 | 0.80 | MAP3K12 (0.39) | MAP3K12METCHRNB2CHRNB4CHRNA3 | |
| SCHEMBL18891653 | 0.79 | ROCK2 (0.43) | MAPK1MAP3K12METCHRNB2CHRNA4 | |
| SCHEMBL18892042 | 0.78 | MAP4K1 (0.47) | MAPK1MAP3K12MET | |
| SCHEMBL20504242 | 0.77 | MAPK1 (0.49) | MAPK1 | |
| SCHEMBL18891802 | 0.77 | ROCK2 (0.45) | MAPK1MAP3K12METCHRNB2CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3377491-B1 | AZAINDOLE DERIVATIVES AND THEIR USE AS ERK KINASE INHIBITORS | AGV DISCOVERY (FR) | 2019-11-13 | — | — | EP | disclosed |